Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

Journal of psychopharmacology (Oxford, England) - 1 Nov 2005

Gough Stephen C L, O'Donovan Michael C

Abstract excerpt

People with schizophrenia are more likely to develop type 2 diabetes than the general population. Although an increased risk of diabetes has been attributed to environmental determinants such as diet, lifestyle and antipsychotic drugs, the association between these two disorders was noticed well...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Comorbidity
Share to Inheritance Patterns

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, Serotonin, 5-HT2A

Share to Receptor, Serotonin, 5-HT2C

Share to Receptors, Serotonin

Share to Schizophrenia

Share to Weight Gain

Source

Identifiers

PMID: 16280337
DOI: 10.1177/0269881105058380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16280337-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?PMID 16280337Read ↗

Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.Semantic proximity Read ↗

Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Genomic insights into the comorbidity between type 2 diabetes and schizophreniaSemantic proximity Read ↗

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.Semantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndromeSemantic proximity Read ↗

Schizophrenia, antipsychotics and diabetes: Genetic aspects.Semantic proximity Read ↗

Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.Semantic proximity Read ↗

At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.Semantic proximity Read ↗

Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.Semantic proximity Read ↗

The Multidimensional Nature of Metabolic Syndrome in Schizophrenia: Lessons from Studies of One-Carbon Metabolism and DNA MethylationSemantic proximity Read ↗

Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.